The FDA has cautioned about “impurities,” the use of an untested “salt” form of semaglutide in compounded drugs, and “adverse ...

State-licensed pharmacies must stop making most compounded semaglutide (copies of Novo Nordisk’s Wegovy and Ozempic) by April 22, and larger outsourcing pharmacies by May 22, or when district ...

A similar lawsuit is being considered on behalf of pharmacies that produce the less expensive versions of semaglutide drugs. Compounded drugs are not approved by the FDA, so the agency does not ...

April 22: Pharmacies must stop compounding semaglutide. May 22 ... call a number or fill a form on our site. Our content is intended to be used for general information purposes only.

Share on Pinterest The FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Images Provided by ...

The FBI says counterfeit versions of the drugs can cause health issues. The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide ...

This case is significant because it creates uncertainty around the FDA’s enforcement deadlines for compounded semaglutide. The association filed a similar lawsuit (Outsourcing Facilities ...

The FDA has cautioned about “impurities,” the use of an untested “salt” form of semaglutide in compounded drugs, and “adverse ...